Recruiting
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
NCT04741997
- Conditions
- BRAF V600 Mutation, Melanoma, Melanoma Stage III, +12 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States